Latest Research in Gastrointestinal Inflammation and Carcinogenesis

Top Research Topics in Gastrointestinal Inflammation and Carcinogenesis

• Inflammatory Bowel Disease — 86 papers
• Hepatocellular Carcinoma Treatment and Prognosis — 38 papers
• Colorectal Cancer Screening and Detection — 38 papers
• Inflammatory Biomarkers in Disease Prognosis — 35 papers
• Celiac Disease Research and Management — 15 papers
• Eosinophilic Esophagitis — 14 papers
• Cholangiocarcinoma and Gallbladder Cancer Studies — 14 papers
• Pancreatic and Hepatic Oncology Research — 12 papers
• Liver Diseases and Immunity — 10 papers
• Global Cancer Incidence and Screening — 9 papers

Highest-Cited Papers

1. Colonoscopy Intervals and Colorectal Cancer Incidence after Adenoma Removal (2 citations)
2. Diagnostic accuracy and prognostic value of lncRNA H19 in gastric cancer: a systematic review and meta-analysis
3. Current and future burden of gastric cancer: an analysis based on CDC WONDER and the global cancer observatory
4. Bridging the Gap Between Endoscopy and Histology Indices: A Multi-Index Comparison in 146 Ulcerative Colitis Patients
5. Comparison of different methods for cell counting in bronchoalveolar lavage fluid
6. Symptom-Based Hospitalization Risk Differs Between Ulcerative Colitis and Crohn’s Disease: A Nationwide Emergency Department Study
7. HALP score in solid tumors: Prognostic value, heterogeneity, and translational considerations
8. COMPARATIVE REAL-WORLD EFFECTIVENESS OF BIOLOGIC THERAPIES FOR PREVENTING POSTOPERATIVE ENDOSCOPIC RECURRENCE OF CROHN’S DISEASE
9. Severe hypertriglyceridemia during adjuvant capecitabine in a patient with factor V Leiden thrombophilia: a case report
10. Clinical outcomes of combined hepatic arterial infusion chemotherapy with targeted or immunotherapy in advanced hepatocellular carcinoma
11. Patterns and Predictors of Germline Testing Completion in Early-Onset Colorectal Cancer: Underuse, Delayed Testing, and Racial Differences in a Multihospital Cohort
12. Factors associated with low skeletal muscle mass and sarcopenia in patients with inflammatory bowel disease: a systematic review and meta-analysis
13. Redefining Early Intervention and the Window of Opportunity in Crohn’s Disease
14. Leucine-rich alpha-2 glycoprotein as a predictor of primary non-response to anti-TNF-α therapy in biologic-naïve Egyptian IBD patients
15. Disparities in initiating standard first-line cancer treatment and survival for patients with an immigrant background: a Danish register-based cohort study
16. Switching standard dosed intravenous to subcutaneous infliximab leads to similar drug exposure in inflammatory bowel disease patients independent of concomitant immunosuppressants (SHUFFLE study)
17. Understanding hepatocellular carcinoma development using longitudinal laboratory measurements
18. Entering the era of disease modification in Crohn’s disease
19. Life expectancy and changing causes of mortality in familial adenomatous polyposis (FAP)
20. Collagenous gastritis in pediatric patients

Sub-Regions

• Inflammatory Bowel Disease — 168 papers
• Inflammatory Biomarkers in Disease Prognosis — 152 papers
• Colorectal Cancer Screening and Detection — 141 papers
• Neuroendocrine Tumor Research Advances — 120 papers
• Bladder and Urothelial Cancer Treatments — 120 papers
• Esophageal Cancer Research and Treatment — 60 papers